Filter
109
Filtered Results: 109
Text search:
remdesivir
Featured
Recommendations
33
New Publications
6
Language
Document type
Guidelines
58
Fact sheets
15
Studies & Reports
12
No document type
8
Manuals
5
Resource Platforms
4
Training Material
3
Strategic & Response Plan
2
Infographics
1
Videos
1
Countries / Regions
Germany
10
Latin America and the Carribbean
9
Brazil
8
Mozambique
6
Angola
6
Congo, Democratic Republic of
5
Rwanda
4
Guinea-Bissau
4
South Sudan
4
India
4
Paraguay
3
East and Southern Africa
3
Uganda
3
China
2
Peru
2
Global
2
West and Central Africa
2
Spain
2
South Africa
2
Russia
2
Liberia
2
Ecuador
2
Switzerland
1
Thailand
1
Kenya
1
Ukraine
1
Chile
1
Senegal
1
Burkina Faso
1
Austria
1
Guinea
1
Africa
1
Middle East and North Africa
1
France
1
Argentina
1
Central African Republic
1
Authors & Publishers
Publication Years
Category
COVID-19
52
Guidelines
31
Drugs & Medical Equipment
4
Studies & Reports
2
Infection Control & Prevention (IPC)
1
Countries
1
Hemorrhagic Fever
1
Medical Devices & Equipment
1
Community Health
1
Information, Education and Communication (IEC)
1
Capacity Building
1
Statistics
1
Health Systems
1
Reproductive Health
1
Pharmacy & Technologies
1
Toolboxes
Clinical Guidelines
47
Country specific documents
41
Treatment Guidelines
9
Scientific & Research Studies
5
Essential Medicines & Medical Devices
5
Essential Medicines & Devices Lists
4
For General Public & Community
3
Training, others
3
For Health Worker
3
Long COVID/ Post-COVID Syndrome
3
Research
2
Prevention & Preparedness
2
Context & Facts, Travel Advice
2
Clinical Aspects
2
Faith-based Organizations
2
Appeals and Response Plans
2
Global Impact: Socio-economic, health services, TB & HIV
2
Oxygen Therapy
2
Fair Allocation & Ethical Aspects
2
Assessment & Studies
1
Situation Reports & Updates
1
COVID-19
1
Public Health
1
Infection Control General
1
Video & Audio
1
Diagnostics & Laboratory Guidance
1
Surveillance & Contact tracing
1
For Pregnant Women
1
Information for the Public
1
Gender Aspects
1
Paediatrics
1
HIV and COVID-19
1
COVID-19
1
Hospital Readiness/Essential Health Services
1
Blood Supply
1
At Home
1
Presentation
1
TB/COVID-19
1
SARS-CoV-2 Variants
1
Others
1
Essential Medicines
1
Prices and Patents
1
Pharmacy Practice
1
Supply Chain & Store Management
1
General Guidelines for Rational Use
1
Reports & Studies
1
Guidelines & Manuals
1
Patient Safety
1
Global Overview
1
Training Material
1
Co-Morbidities (except TB)
1
Human Rights & the Right to Health
1
Clinical Guidelines
1
Infection Control
1
Marburg Virus Situation Reports
1
Preparedness & Prevention
1
These forms are intended only for clinicians and nurses taking care of patients with Ebola virus disease. They provide standardized information that needs to be collected by the clinicians at admission time, every day and at time of discharge.
16.7.2021
O Centro Africano de Prevenção e Luta contra Doenças (CDC-África) está preocupado com a divulgação de informações incorrectas através de meios de comunicação tradicionais e sociais sobre a prevenção e o tratamento de nova doença de coronavírus (COVID-19).
Março de 2020
O número de Estados Membros da União Africana a reportarem
casos do COVID-19 está a aumentar e existe uma probabilidade de transmissão comunitária. A OMS modificou recentemente a definição
de caso suspeito do COVID-19, de modo a incluir infecção respiratória aguda grave...
Erfahrungen im Umgang mit COVID-19-Erkrankten–Hinweise von Klinikern für Kliniker –
As of 31 October 2020 This is the tenth edition of this summary of rapid systematic reviews, which includes the results of a rapid systematic review of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. I...
This twelfth version of the WHO living guideline now contains 19 recommendations. This latest update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blockers and Janus kinase (JAK) inhibitors in patients wi...
If you have COVID-19 and are caring for someone or yourself at home, what is the treatment protocol? What is WHO’s guidance on Remdesivir and convalescent plasma therapy? How to monitor oxygen at home and what are the red flags when you should call the doctor? WHO’s Dr Janet Diaz explains in Sci...
A living WHO guideline on drugs for covid-19
recommended
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access for clarity. The publication of the RE...
3 March 2022
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an ...
16.7.2021
The purpose of this document is to stop to irrational use/ over prescription of this reserve/
experimental/ emergency use authorisation drug Remdesivir. For this reason, Joint
Monitoring Group under Chairmanship of DGHS took into consideration findings of the
followi...
Updated Treatment Guidelines
Guía de tratamiento farmacológico y manejo deescenarios clínicos de casos de COVID-19 – enero 2022 Guía de tratamiento farmacológico y manejo deLeer más
Remdesivir for COVID-19
recommended
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
Administration of Remdesivir for COVID-19
recommended
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for...
